Share and Bond information

Roche's non-voting equity securities and Roche bearer shares are listed on SIX Swiss Exchange. Roche’s American Depositary Receipt (ADR) is listed on OTCQX International Premier under the ticker RHHBY.

The Company has a share capital of CHF 106,691,000, divided into 106,691,000 fully paid bearer shares with a nominal value of 1 Swiss franc each. There are no limitations on the transfer of these shares and no shares with maximum voting rights (please refer to § 3ss. of the Articles of Incorporation of Roche Holding Ltd.).

In addition, 702,562,700 non-voting equity securities have been issued in bearer form. Roche’s non-voting equity securities and the rights pertaining thereto are described in §4ss. of the Articles of Incorporation of Roche Holding Ltd.

For more information, please read the

At 31 December 2023, based on the information available to the Group, a shareholder group with pooled voting rights owned 69,318,000 shares representing 64.97% of the issued shares (31 December 2022: 72,018,000 shares representing 67.50% of the issued shares). On 5 December 2019 the shareholder group announced that it would continue the shareholder pooling agreement with a modified shareholder composition. This group now consists of Mr André Hoffmann, Ms Marie-Anne Hoffmann, Ms Vera Michalski, Mr Alexander Hoffmann, Mr Frederic Hoffmann, Ms Isabel Hoffmann, Mr Lucas Hoffmann, Ms Marina Hoffmann, Ms Kasia Barbotin-Larrieu, Ms Tatiana Fabre, Mr Andreas Oeri, Ms Catherine Oeri, Ms Sabine Duschmalé, Mr Jörg Duschmalé, Mr Lukas Duschmalé, the charitable foundation Wolf and Artuma Holding LLC. The shareholder pooling agreement has existed since 1948. The duration of the pool was extended for an indefinite period in 2009. At 31 December 2023, based on the information available to the Group, Ms Maja Oeri, formerly a member of the pool, held 8,091,900 shares independently of the pool, representing 7.58% of the issued shares (31 December 2022: 8,091,900 shares representing 7.58% of the issued shares).

Equity research on Roche is provided by the following institutions. We provide the names of institutions for your convenience only. We do not endorse or express any opinion on their reports and expressly disclaim any liability for any of their statements and for the use of such third party information. The list does not purport to be complete, correct or representative. The list may be updated from time to time, but no assurance is given that the list is current or accurate as of any point in time.

Institutions
  • Bank of America

  • Bank Vontobel AG

  • Barclays

  • Berenberg

  • Bernstein

  • Citi

  • Cowen & Co

  • Deutsche Bank

  • Exane BNP Paribas

  • HSBC

  • Intron Health

  • Jefferies

  • JPMorgan

  • Kepler Cheuvreux

  • Morgan Stanley

  • Morningstar Inc

  • ODDO Securities

  • Redburn (Europe) Limited

  • Stifel

  • UBS

  • Wolfe Research

  • Zürcher Kantonalbank (ZKB)

Timetable for payment of the 2023 dividend

The next Annual General Meeting of Roche Holding Ltd is expected to take place on 25 March 2025.

Timetable for payment of the 2023 dividend

  1. Declaration date is the date of approval of the proposed dividend at the Annual General Meeting

  2. Ex-dividend date is the first date where trading takes place without dividend

  3. Record date is the last date on which the security must be held in custody in order to be eligible to receive dividend (as settlement typically takes place trading day + 2days)

  4. Roche dividend to ADR holders will be paid upon completion of the Swiss withholding tax reclaim process.

This investor tool provides advanced analysis of total returns over time including dividend history and a calculator that can be used to determine the value and total return of your investment.
Number of shares and non-voting equity securities a)
Data per share and non-voting equity security in CHF
Market capitalisation in millions of CHF
Key ratios (year-end)

a) Each non-voting equity security (Genussschein) confers the same rights as any of the shares to participate in the available earnings and any remaining proceeds from liquidation following repayment of the nominal value of the shares and the participation certificate capital (if any). Shares and non-voting equity securities are listed on the SIX Swiss Exchange. Roche Holding Ltd has no restrictions as to ownership of its shares or non-voting equity securities.

b) All stock price data reflect daily closing prices.

Yearly Dividend Payout

Bond information

Last update: June 2024


Bond maturity profile

Information about Roche's current bonds and notes

This is not an offer of Securities for sale. The Bonds and Notes have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Bonds and Notes may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S) except in transactions exempt from, or not subject to, the registration requirements of the Securities Act.

Roche Finance Europe B.V. (The Netherlands) guaranteed by Roche Holding Ltd (Switzerland)
EMTN Programme; listed in Luxembourg
EUR standalone, primary listing at SIX (Switzerland)
Roche Kapitalmarkt AG (Switzerland) guaranteed by Roche Holding Ltd (Switzerland)
Swiss issuer: 35% withholding tax on coupon payments Standalone Swiss documentation; listed at SIX (Switzerland)
Roche Holdings, Inc. (USA) guaranteed by Roche Holding Ltd (Switzerland)
144a / RegS US documentation; not listed
Genentech, Inc.
US documentation, not listed

Credit Rating

Last update: October, 2022

Credit Rating of Roche Holding Ltd

Downloads

Annual Reports 2023
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2023
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2022
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2022
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2021
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2021
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2020
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2020
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2019
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2019
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2018
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2018
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Annual Reports 2017
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG
Half-Year Reports 2017
Roche Holdings, Inc.Roche Finance Europe B.V.Roche Kapitalmarkt AG

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement